Cardiogenic Acute Pulmonary Edema

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Cardiogenic Acute Pulmonary Edema trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT05989139

HF vs NIV in Acute Cardiogenic Pulmonary Edema

The study's primary aim is * to compare the effects of two different ventilation modalities, non-invasive positive-pressure ventilation (NPPV) and high-flow na…

Italy30 participantsStarted 2024-01-01

Treatment: NPPV/HFNC, HFNC/NPPV

All recent trials (26 shown)

CompletedPhase 3

NCT00213681

CPAP Versus Bilevel Pressure Support Ventilation in Cardiogenic Pulmonary Edema

To evaluate whether bilevel positive airway pressure more rapidly improves ventilation than continuous positive airway pressure (CPAP) in patients with acute pu…

Location not specifiedStarted 2002-11

Treatment: Boussignac CPAP - bilevel ventilation support

CompletedNot Applicable

NCT07338227

Validation of Clara Cell Protein as a Novel Diagnostic Biomarker for the Differentiation of Cardiogenic Pulmonary Edema…

This study aimed to validate the use of clara cell secretory protein (CC16) as a biomarker for differentiating between cardiogenic pulmonary edema (CPE) and non…

Egypt100 participantsStarted 2023-01-01

Treatment: Clara cell protein 16

Cardiogenic Acute Pulmonary Edema

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

HF vs NIV in Acute Cardiogenic Pulmonary Edema

All recent trials (26 shown)

CPAP Versus Bilevel Pressure Support Ventilation in Cardiogenic Pulmonary Edema

Validation of Clara Cell Protein as a Novel Diagnostic Biomarker for the Differentiation of Cardiogenic Pulmonary Edema…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

HF vs NIV in Acute Cardiogenic Pulmonary Edema

All recent trials (26 shown)

CPAP Versus Bilevel Pressure Support Ventilation in Cardiogenic Pulmonary Edema

Validation of Clara Cell Protein as a Novel Diagnostic Biomarker for the Differentiation of Cardiogenic Pulmonary Edema…

Morphine, Midazolam and Dexmedetomidine in the Management of Acute Cardiogenic Pulmonary Edema, Safety and Efficacy

Helmet CPAP vs Facemask CPAP in ACPE (hCPAP vs fCPAP)

Obstructive Sleep Apnea Treatment on Cardiovascular Events in Patients With Acute Cardiogenic Pulmonary Edema: CPAP-CARE…

Initial Volume Status in Patients With Acute Brain Injury is Associated With Neurological Prognosis

Cardiogenic Acute Pulmonary Edema in Subjects Over 75 Years Old: Impact of Non-invasive Ventilation on Mortality

Prevalence of Venous conGestion and Its Association With Renal Injuries Evaluated by the VExUS Score On Admission With U…

HIgh Flow Versus NIV for Acute Cardiogenic PuLmonary Oedema With Acute Respiratory Failure in an ED

Ultra Protective Ventilation During Venoarterial Extracorporeal Membrane Oxygenation (UPV-ECMO)

Helmet CPAP Versus HFNC in Acute Cardiogenic Pulmonary Edema

Non-Invasive Ventilation Via a Helmet Device for Patients Respiratory Failure

Milrinone Versus Dobutamine in Critically Ill Patients

High Flow Nasal Cannula Therapy for Early Management of Acute Hypercapnic Cardiogenic Pulmonary Edema in the Emergency D…

High Flow Nasal Oxygen Versus VNI in Acute Hypercapnic Cardiogenic Pulmonary Edema

Non-invasive Ventilation Versus Continuous Positive Airway Pressure in Cardiogenic Pulmonary Edema

OUT-OF-HOSPITAL CPAP STUDY

Epidemiology and Prognostic of the Acute Heart Failure

Predictors of Non-invasive Ventilation Failure in Patients With Acute Cardiogenic Pulmonary Edema

Acute Congestive Heart Failure